Press Release |
Where We Are Headed -- New Outlook on Bristol-Myers Squibb Company and AstraZeneca Plc
* Reuters is not responsible for the content in this press release.
JAKARTA, INDONESIA, Oct 24 (Marketwire) -- Moments ago, NationalTradersAssociation.org introduced new coverage of Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca Plc (NYSE: AZN). Full outlook, analysis and consensus opinion is available to readers via the links below. www.NationalTradersAssociation.org/r/gov/8428_BMY www.NationalTradersAssociation.org/r/gov/2770_AZN The consistent delivery of accurate analyses relies solely on two factors, namely: market awareness and industry insight. Recent market drivers include the spark of U.S. housing starts soaring past expectations to a four-year high in September, industrial production rising 0.4% in September 2012 beating expectations for a 0.2% increase and the recent upward surprise in initial jobless claims bouncing upward to 388,000 above expectations of 365,000 in the latest week. When it comes to discovering the right edge at the right time, all these factors play into effect. For a deeper understanding of the mechanics behind these events and how it can affect your portfolio, please refer to our email newsletter delivered to your inbox. National Traders Association is releasing new coverage on Bristol-Myers Squibb Company for its current position within the consumer durables sector. Bristol-Myers Squibb Company (BMS) is a global biopharmaceutical company. The Company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products on a global basis. A copy of this report featuring Bristol-Myers Squibb Company (NYSE: BMY) is available at: www.NationalTradersAssociation.org/r/gov/8428_BMY. National Traders Association has released research on AstraZeneca Plc for its changing role within the consumer durables sector. AstraZeneca PLC (AstraZeneca) is a global biopharmaceutical company. AstraZeneca discovers, develops and commercializes prescription medicines for six areas of healthcare: Cardiovascular, Gastrointestinal, Infection, Neuroscience, Oncology, and Respiratory and Inflammation. To access the full research report on AstraZeneca Plc (NYSE: AZN) we welcome investors to visit: www.NationalTradersAssociation.org/r/gov/2770_AZN. Consider National Traders Association Tired of hearing about the latest, greatest trade opportunity... only to realize that the ship has long sailed? You need a strong, informative community in your arsenal. Join the group that has been consistently identifying momentous situations as they develop -- long before they become the next top news on major financial networks. Contact: Demi Lapierre press@NationalTradersAssociation.org www.NationalTradersAssociation.org Copyright 2012, Marketwire, All rights reserved. -0-